[go: up one dir, main page]

PH12012501972A1 - Crystalline peptide epoxyketone immunoproteasome inhibitor - Google Patents

Crystalline peptide epoxyketone immunoproteasome inhibitor

Info

Publication number
PH12012501972A1
PH12012501972A1 PH1/2012/501972A PH12012501972A PH12012501972A1 PH 12012501972 A1 PH12012501972 A1 PH 12012501972A1 PH 12012501972 A PH12012501972 A PH 12012501972A PH 12012501972 A1 PH12012501972 A1 PH 12012501972A1
Authority
PH
Philippines
Prior art keywords
peptide epoxyketone
crystalline peptide
immunoproteasome inhibitor
crystalline
epoxyketone immunoproteasome
Prior art date
Application number
PH1/2012/501972A
Inventor
Pasit Phiasivongsa
Original Assignee
Onyx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Therapeutics Inc filed Critical Onyx Therapeutics Inc
Priority claimed from PCT/US2011/031436 external-priority patent/WO2011136905A2/en
Publication of PH12012501972A1 publication Critical patent/PH12012501972A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to crystalline peptide keto epoxide compounds, methods of their preparation, and related pharmaceutical compositions.
PH1/2012/501972A 2010-04-07 2011-04-06 Crystalline peptide epoxyketone immunoproteasome inhibitor PH12012501972A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP61321577 2010-04-07
PCT/US2011/031436 WO2011136905A2 (en) 2010-04-07 2011-04-06 Crystalline peptide epoxyketone immunoproteasome inhibitor

Publications (1)

Publication Number Publication Date
PH12012501972A1 true PH12012501972A1 (en) 2013-01-07

Family

ID=94176969

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/501972A PH12012501972A1 (en) 2010-04-07 2011-04-06 Crystalline peptide epoxyketone immunoproteasome inhibitor

Country Status (1)

Country Link
PH (1) PH12012501972A1 (en)

Similar Documents

Publication Publication Date Title
MY156522A (en) Crystalline tripeptide epoxy ketone protease inhibitors
WO2011136905A3 (en) Crystalline peptide epoxyketone immunoproteasome inhibitor
JOP20180102A1 (en) Pharmaceutical composition
MX2018001990A (en) Compositions comprising a pi3k inhibitor and an hdac inhibitor.
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
WO2011153157A3 (en) Benzoquinolone inhibitors of vmat2
ZA201301329B (en) Novel compounds and compositions for the inhibition of nampt
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
MX2013000793A (en) Galacto-oligosaccharide-containing composition and a method of producing it.
MX340147B (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
EA201490756A1 (en) CITRAMID RAZAGLININA
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
MX362879B (en) Novel uses.
EA201300034A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IMATINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, AND WAYS TO OBTAIN THEM
WO2011123524A3 (en) Macrolide inhibitors of mtor
WO2012154879A3 (en) Autophagy inhibitors
PH12013500210A1 (en) Highly crystalline valsartan
EP2568810A4 (en) Darunavir compositions
WO2014008204A3 (en) Structures of proteasome inhibitors and methods for synthesizing and use thereof
PH12012501972A1 (en) Crystalline peptide epoxyketone immunoproteasome inhibitor
MX2013007504A (en) Compositions and methods of using crystalline forms of wortmannin analogs.
EP2543373A4 (en) Compound pharmaceutical composition of levoamlodipine
GB2509470A (en) Pharmaceutical compositions of antihypertensives
MY169279A (en) A medicinal composition
MX2015007959A (en) Polymorph.